{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:18:15Z","timestamp":1787980695314,"version":"build-2784847793"},"reference-count":93,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5582\/bst.2026.01106","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:11:17Z","timestamp":1787695877000},"source":"Crossref","is-referenced-by-count":0,"title":["Cholinergic dysfunction in Alzheimer's disease: Mechanistic perspectives and multi-target effects of traditional Chinese medicine"],"prefix":"10.5582","author":[{"given":"Yixin","family":"Wang","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Hebei University, Baoding, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Li","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hebei University, Baoding, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Hao","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hebei University, Baoding, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pai","family":"Guo","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hebei University, Baoding, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyan","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hebei University, Baoding, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital of Hebei University, Baoding, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Li","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hebei University, Baoding, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nguyen TT, Giau VV, Vo TK. Current advances in transdermal delivery of drugs for Alzheimer&apos;s disease. Indian J Pharmacol. 2017; 49:145-154.","DOI":"10.4103\/0253-7613.208143"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhi N, Ren R, Qi J, <i>et al<\/i>. The China Alzheimer Report 2025. Gen Psychiatr. 2025; 38:e102020.","DOI":"10.1136\/gpsych-2024-102020"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ahmed TF, Ahmed A, Imtiaz F. History in perspective: How Alzheimer&apos;s disease came to be where it is? Brain Res. 2021; 1758:147342.","DOI":"10.1016\/j.brainres.2021.147342"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Allard S, Hussain Shuler MG. Cholinergic reinforcement signaling is impaired by amyloidosis prior to its synaptic loss. J Neurosci. 2023; 43:6988-7005.","DOI":"10.1523\/JNEUROSCI.0967-23.2023"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Khan S, Barve KH, Kumar MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer&apos;s disease. Curr Neuropharmacol. 2020; 18:1106-1125.","DOI":"10.2174\/1570159X18666200528142429"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wu CK, Fuh JL. A 2025 update on treatment strategies for the Alzheimer&apos;s disease spectrum. J Chin Med Assoc. 2025; 88:495-502.","DOI":"10.1097\/JCMA.0000000000001252"},{"key":"7","unstructured":"7. Liu X, Zhang R, Li C, Li W. Research progress of treating Alzheimer&apos;s disease with traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi. 2025; 50:1146-1154. (in Chinese)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bekdash RA. The cholinergic system, the adrenergic system and the neuropathology of Alzheimer&apos;s disease. Int J Mol Sci. 2021; 22:1273.","DOI":"10.3390\/ijms22031273"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer&apos;s disease: Targeting the cholinergic system. Curr Neuropharmacol. 2016; 14:101-115.","DOI":"10.2174\/1570159X13666150716165726"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Anni D, Weiss EM, Guhathakurta D, Akdas YE, Klueva J, Zeitler S, Andres-Alonso M, Huth T, Fejtova A. A\u03b21-16 controls synaptic vesicle pools at excitatory synapses <i>via<\/i> cholinergic modulation of synapsin phosphorylation. Cell Mol Life Sci. 2021; 78:4973-4992.","DOI":"10.1007\/s00018-021-03835-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lecrux C, Sandoe CH, Neupane S, Kropf P, Toussay X, Tong XK, Liu Y, Lecrux M, Shmuel A, Hamel E. Impact of altered cholinergic tones on the neurovascular coupling response to whisker stimulation. J Neurosci. 2017; 37:1518-1531.","DOI":"10.1523\/JNEUROSCI.1784-16.2016"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Simchovitz A, Heneka MT, Soreq H. Personalized genetics of the cholinergic blockade of neuroinflammation. J Neurochem. 2017; 142 Suppl 2:178-187.","DOI":"10.1111\/jnc.13928"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Martinez-Rubio C, Paulk AC, McDonald EJ, Widge AS, Eskandar EN. Multimodal encoding of novelty, reward, and learning in the primate nucleus basalis of Meynert. J Neurosci. 2018; 38:1942-1958.","DOI":"10.1523\/JNEUROSCI.2021-17.2017"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Dani JA. Neuronal nicotinic acetylcholine receptor structure and function and response to nicotine. Int Rev Neurobiol. 2015; 124:3-19.","DOI":"10.1016\/bs.irn.2015.07.001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kadir A, Almkvist O, Wall A, L\u00e5ngstr\u00f6m B, Nordberg A. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer&apos;s disease. Psychopharmacology (Berl). 2006; 188:509-520.","DOI":"10.1007\/s00213-006-0447-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ma KG, Qian YH. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer&apos;s disease. Neuropeptides. 2019; 73:96-106.","DOI":"10.1016\/j.npep.2018.12.003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rennie K. Neuronal and glial \u03b17 nicotinic acetylcholine receptors: Role in Alzheimer&apos;s disease pathophysiology. Life (Basel). 2025; 15:1032.","DOI":"10.3390\/life15071032"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yu WF, Guan ZZ, Bogdanovic N, Nordberg A. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer&apos;s disease and patients carrying Swedish APP 670\/671 mutation: A possible association with neuritic plaques. Exp Neurol. 2005; 192:215-225.","DOI":"10.1016\/j.expneurol.2004.12.015"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. George AA, Vieira JM, Xavier-Jackson C, Gee MT, Cirrito JR, Bimonte-Nelson HA, Picciotto MR, Lukas RJ, Whiteaker P. Implications of oligomeric amyloid-beta (oA\u03b2(42)) signaling through \u03b17\u03b22-nicotinic acetylcholine receptors (nAChRs) on basal forebrain cholinergic neuronal intrinsic excitability and cognitive decline. J Neurosci. 2021; 41:555-575.","DOI":"10.1523\/JNEUROSCI.0876-20.2020"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Jiang S, Li Y, Zhang C, Zhao Y, Bu G, Xu H, Zhang YW. M1 muscarinic acetylcholine receptor in Alzheimer&apos;s disease. Neurosci Bull. 2014; 30:295-307.","DOI":"10.1007\/s12264-013-1406-z"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Moran SP, Maksymetz J, Conn PJ. Targeting muscarinic acetylcholine receptors for the treatment of psychiatric and neurological disorders. Trends Pharmacol Sci. 2019; 40:1006-1020.","DOI":"10.1016\/j.tips.2019.10.007"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Thomsen M, S\u00f8rensen G, Dencker D. Physiological roles of CNS muscarinic receptors gained from knockout mice. Neuropharmacology. 2018; 136(Pt C):411-420.","DOI":"10.1016\/j.neuropharm.2017.09.011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Gulledge AT, Bucci DJ, Zhang SS, Matsui M, Yeh HH. M1 receptors mediate cholinergic modulation of excitability in neocortical pyramidal neurons. J Neurosci. 2009; 29:9888-9902.","DOI":"10.1523\/JNEUROSCI.1366-09.2009"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Conley AC, Key AP, Blackford JU, Russell JK, Albert KM, Gong X, Bubser M, Rook JM, Conn PJ, Lindsley CW, Jones CK, Newhouse PA. Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M(1) positive allosteric modulator VU0467319 for Alzheimer&apos;s disease: A single ascending-dose study in healthy participants. Alzheimers Res Ther. 2025; 17:144.","DOI":"10.1186\/s13195-025-01798-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kent SA, Spires-Jones TL, Durrant CS. The physiological roles of tau and A\u03b2: implications for Alzheimer&apos;s disease pathology and therapeutics. Acta Neuropathol. 2020; 140:417-447.","DOI":"10.1007\/s00401-020-02196-w"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Beach TG, Kuo YM, Spiegel K, Emmerling MR, Sue LI, Kokjohn K, Roher AE. The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease. J Neuropathol Exp Neurol. 2000; 59:308-313.","DOI":"10.1093\/jnen\/59.4.308"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Apelt J, Kumar A, Schliebs R. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein. Brain Res. 2002; 953(1-2):17-30.","DOI":"10.1016\/S0006-8993(02)03262-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Varshney V, Garabadu D. Ang (1-7)\/Mas receptor-axis activation promotes amyloid beta-induced altered mitochondrial bioenergetics in discrete brain regions of Alzheimer&apos;s disease-like rats. Neuropeptides. 2021; 86:102122.","DOI":"10.1016\/j.npep.2021.102122"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Li S, Jin M, Koeglsperger T, Shepardson NE, Shankar GM, Selkoe DJ. Soluble A\u03b2 oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J Neurosci. 2011; 31:6627-6638.","DOI":"10.1523\/JNEUROSCI.0203-11.2011"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ashrafian H, Zadeh EH, Khan RH. Review on Alzheimer&apos;s disease: Inhibition of amyloid beta and tau tangle formation. Int J Biol Macromol. 2021; 167:382-394.","DOI":"10.1016\/j.ijbiomac.2020.11.192"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Nelson PT, Alafuzoff I, Bigio EH, <i>et al<\/i>. Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature. J Neuropathol Exp Neurol. 2012; 71:362-381.","DOI":"10.1097\/NEN.0b013e31825018f7"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ramos-Rodriguez JJ, Pacheco-Herrero M, Thyssen D, Murillo-Carretero MI, Berrocoso E, Spires-Jones TL, Bacskai BJ, Garcia-Alloza M. Rapid \u03b2-amyloid deposition and cognitive impairment after cholinergic denervation in APP\/PS1 mice. J Neuropathol Exp Neurol. 2013; 72:272-285.","DOI":"10.1097\/NEN.0b013e318288a8dd"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Shafiei SS, Guerrero-Mu\u00f1oz MJ, Castillo-Carranza DL. Tau oligomers: Cytotoxicity, propagation, and mitochondrial damage. Front Aging Neurosci. 2017; 9:83.","DOI":"10.3389\/fnagi.2017.00083"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000; 405:458-462.","DOI":"10.1038\/35013070"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pampuscenko K, Morkuniene R, Krasauskas L, Smirnovas V, Brown GC, Borutaite V. Extracellular tau stimulates phagocytosis of living neurons by activated microglia <i>via<\/i> Toll-like 4 receptor-NLRP3 inflammasome-caspase-1 signalling axis. Sci Rep. 2023; 13:10813.","DOI":"10.1038\/s41598-023-37887-3"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Friker LL, Scheiblich H, Hochheiser IV, Brinkschulte R, Riedel D, Latz E, Geyer M, Heneka MT. \u03b2-amyloid clustering around ASC fibrils boosts its toxicity in microglia. Cell Rep. 2020; 30:3743-3754.e6.","DOI":"10.1016\/j.celrep.2020.02.025"},{"key":"37","unstructured":"37. Yu H, Sun M, Wang F, Kang S, Han G, Li D, Zhen W, Ma T. Mechanism of Dihuang Yinzi in improving astrocyte injury and glycolysis in AD mice <i>via<\/i> the PI3K\/Akt pathway. Zhongguo Shiyan Fangjixue Zazhi. 2023; 29:10-18. (in Chinese)."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer&apos;s disease. J Alzheimers Dis. 2018; 62:1403-1416.","DOI":"10.3233\/JAD-170585"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Liu PP, Xie Y, Meng XY, Kang JS. History and progress of hypotheses and clinical trials for Alzheimer&apos;s disease. Signal Transduct Target Ther. 2019; 4:29.","DOI":"10.1038\/s41392-019-0063-8"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Wilkins HM, Koppel S, Carl SM, Ramanujan S, Weidling I, Michaelis ML, Michaelis EK, Swerdlow RH. Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure. J Neurochem. 2016; 137:76-87.","DOI":"10.1111\/jnc.13545"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Krzywoszy\u0144ska K, Witkowska D, \u015awi\u0105tek-Koz\u0142owska J, Szebesczyk A, Koz\u0142owski H. General aspects of metal ions as signaling agents in health and disease. Biomolecules. 2020; 10:1417.","DOI":"10.3390\/biom10101417"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Jasiecki J, Targo\u0144ska M, Was\u0105g B. The role of butyrylcholinesterase and iron in the regulation of cholinergic network and cognitive dysfunction in Alzheimer&apos;s disease pathogenesis. Int J Mol Sci. 2021; 22:2033.","DOI":"10.3390\/ijms22042033"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Lei P, Ayton S, Bush AI. The essential elements of Alzheimer&apos;s disease. J Biol Chem. 2021; 296:100105.","DOI":"10.1074\/jbc.REV120.008207"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Zheng N, Zhou Q, Chen Z, Xie L, Yang X, Chen Z, Wang F, Sun Q, Du J, Lin J, Li L, Li B. Cuproptosis: Mechanisms and links with Alzheimer&apos;s disease. J Neurophysiol. 2025; 134:1853-1876.","DOI":"10.1152\/jn.00370.2025"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. N\u00fa\u00f1ez MT, Hidalgo C. Noxious iron-calcium connections in neurodegeneration. Front Neurosci. 2019; 13:48.","DOI":"10.3389\/fnins.2019.00048"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. G\u00f3mez-Gonzalo M, Martin-Fernandez M, Mart\u00ednez-Murillo R, Mederos S, Hern\u00e1ndez-Vivanco A, Jamison S, Fernandez AP, Serrano J, Calero P, Futch HS, Corpas R, Sanfeliu C, Perea G, Araque A. Neuron-astrocyte signaling is preserved in the aging brain. Glia. 2017; 65:569-580.","DOI":"10.1002\/glia.23112"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer&apos;s disease: Advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021; 20:68-80.","DOI":"10.1016\/S1474-4422(20)30412-9"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci U S A. 1995; 92:12260-12264.","DOI":"10.1073\/pnas.92.26.12260"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Bott JB, H\u00e9raud C, Cosquer B, Herbeaux K, Aubert J, Sartori M, Goutagny R, Mathis C. APOE-sensitive cholinergic sprouting compensates for hippocampal dysfunctions due to reduced entorhinal input. J Neurosci. 2016; 36:10472-10486.","DOI":"10.1523\/JNEUROSCI.1174-16.2016"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Lai MK, Tsang SW, Garcia-Alloza M, Minger SL, Nicoll JA, Esiri MM, Wong PT, Chen CP, Ram\u00edrez MJ, Francis PT. Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer&apos;s disease. Neurobiol Dis. 2006; 22:555-561.","DOI":"10.1016\/j.nbd.2005.12.016"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Huynh TV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H, Roh J, Finn MB, Sullivan PM, Esparza TJ, Stewart FR, Mahan TE, Ulrich JD, Cole T, Holtzman DM. Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis. Neuron. 2017; 96:1013-1023.e4.","DOI":"10.1016\/j.neuron.2017.11.014"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Kumar R, Nordberg A, Darreh-Shori T. Amyloid-\u03b2 peptides act as allosteric modulators of cholinergic signalling through formation of soluble BA\u03b2ACs. Brain. 2016; 139(Pt 1):174-192.","DOI":"10.1093\/brain\/awv318"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Wang CY, Zheng W, Wang T, Xie JW, Wang SL, Zhao BL, Teng WP, Wang ZY. Huperzine A activates Wnt\/\u03b2-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model. Neuropsychopharmacology. 2011; 36:1073-1089.","DOI":"10.1038\/npp.2010.245"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Nakajima A, Yamakuni T, Haraguchi M, Omae N, Song SY, Kato C, Nakagawasai O, Tadano T, Yokosuka A, Mimaki Y, Sashida Y, Ohizumi Y. Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice. J Pharmacol Sci. 2007; 105:122-126.","DOI":"10.1254\/jphs.SC0070155"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Wang C, Cai X, Hu W, Li Z, Kong F, Chen X, Wang D. Investigation of the neuroprotective effects of crocin <i>via<\/i> antioxidant activities in HT22 cells and in mice with Alzheimer&apos;s disease. Int J Mol Med. 2019; 43:956-966.","DOI":"10.3892\/ijmm.2018.4032"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Zhao C, Zhang H, Li H, Lv C, Liu X, Li Z, Xin W, Wang Y, Zhang W. Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice. Neuropharmacology. 2017; 116:18-29.","DOI":"10.1016\/j.neuropharm.2016.12.002"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Yang HJ, Zhang T, Kim MJ, Hur HJ, Wu X, Jang DJ, Park S. Efficacy and mechanism of Schisandra chinensis Fructus water extract in Alzheimer&apos;s disease: Insights from network pharmacology and validation in an amyloid-\u03b2-infused animal model. Nutrients. 2024; 16:3751.","DOI":"10.3390\/nu16213751"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Li HQ, I p SP, Zheng GQ, Xian YF, Lin ZX. Isorhynchophylline alleviates learning and memory impairments induced by aluminum chloride in mice. Chin Med. 2018; 13:29.","DOI":"10.1186\/s13020-018-0187-8"},{"key":"59","unstructured":"59. Wang HP, Wu HY, Li HL, Ma CL, Zeng QT, Cui SM, Zhu KM. Effects of angelica polysaccharide on learning and memory abilities and A\u03b2 metabolism in model rats with Alzheimer disease. Zhongguo Zhongyiyao Xinxi Zazhi. 2018; 25:51-55. (in Chinese)."},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Lu C, Dong L, Lv J, Wang Y, Fan B, Wang F, Liu X. 20(S)-protopanaxadiol (PPD) alleviates scopolamine-induced memory impairment <i>via<\/i> regulation of cholinergic and antioxidant systems, and expression of Egr-1, c-Fos and c-Jun in mice. Chem Biol Interact. 2018; 279:64-72.","DOI":"10.1016\/j.cbi.2017.11.008"},{"key":"61","unstructured":"61. Zhao J. Mechanism of Shichangpu in the treatment of dementia in a quasi-Alzheimer disease rat model [master&apos;s thesis]. Hubei University of Chinese Medicine, Wuhan, China, 2017. (in Chinese)."},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. She L, Sun J, Xiong L, Li A, Li L, Wu H, Ren J, Wang W, Liang G, Zhao X. Ginsenoside RK1 improves cognitive impairments and pathological changes in Alzheimer&apos;s disease <i>via<\/i> stimulation of the AMPK\/Nrf2 signaling pathway. Phytomedicine. 2024; 122:155168.","DOI":"10.1016\/j.phymed.2023.155168"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Li Y, Dai S, Huang N, Wu J, Yu C, Luo Y. Icaritin and icariin reduce p-Tau levels in a cell model of Alzheimer&apos;s disease by downregulating glycogen synthase kinase 3\u03b2. Biotechnol Appl Biochem. 2022; 69:355-363.","DOI":"10.1002\/bab.2114"},{"key":"64","unstructured":"64. Yan L. Effects and underlying mechanisms of icariside II on spatial learning and memory impairment in Alzheimer&apos;s disease model mice [master&apos;s thesis]. Zunyi Medical University, Zunyi, China, 2017. (in Chinese)."},{"key":"65","unstructured":"65. Dong J, Han Z. Effects of combination of Ligusticum chuanxiong active substance ethyl ferulate and aerobic exercise on cognitive function of Alzheimer&apos;s disease rats. Zhongguo Shipin Weisheng Zazhi. 2024; 36:659-666. (in Chinese)."},{"key":"66","unstructured":"66. Cao L, Dong C, Yang Y, Liang Y, Luo Y, Xie Z, Wang J, Xia B, Wu W. Effect of Huanglian Jiedutang on learning and memory ability and the cholinergic system in AD rats induced by A\u03b2<sub>1-42<\/sub>. Zhongguo Shiyan Fangjixue Zazhi. 2021; 27:23-30. (in Chinese)."},{"key":"67","unstructured":"67. Liu Y, Jiang Y, Sun Y, Wang F, Hou X. Effects and pharmacokinetic changes of Danggui-Shaoyao-San on the central cholinergic pathway in female IBO rats. Shijie Kexue Jishu Zhongyiyao Xiandaihua. 2025; 1-11. (in Chinese)."},{"key":"68","unstructured":"68. He X, Wang X, Min D, Wang X, Cheng M, Liu Y, Ju Y, Yang Y, Yuan C, Yu C, Zhang L. Mechanism of action of Kaixinsan in ameliorating Alzheimer&apos;s disease. Zhongguo Shiyan Fangjixue Zazhi. 2025; 31:20-29. (in Chinese)."},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Lo TY, Chan ASL, Cheung ST, Yung LY, Leung MMH, Wong YH. Multi-target regulatory mechanism of Yang Xin Tang: A traditional Chinese medicine against dementia. Chin Med. 2023; 18:101.","DOI":"10.1186\/s13020-023-00813-w"},{"key":"70","unstructured":"70. Chen X, Tang L, Ren D, Zhao L. Efficacy and safety of huperzine A in treatment of Alzheimer&apos;s disease based on systematic review and sequential analysis of experiments. Yaowu Pingjia Yanjiu. 2025; 48:496-509. (in Chinese)."},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Riepe M, Hoerr R, Schlaefke S. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia: A meta-analysis of patient subgroups in randomised controlled trials. World J Biol Psychiatry. 2025; 26:119-129.","DOI":"10.1080\/15622975.2024.2446830"},{"key":"72","unstructured":"72. Liu Z, Zhao L, Sun TF. Effects of Buyuan Congao Decoction combined with piracetam on blood-brain barrier, cognitive function, serum IGF-1 and A\u03b2 in senile dementia patients. Zhongyiyao Linchuang Zazhi. 2024; 36:518-522. (in Chinese)."},{"key":"73","unstructured":"73. Hui T, Lin X, Liu H. Clinical study of Dihuang-Yinzi Decoction combined with donepezil hydrochloride tablets in the treatment of mild-to-moderate Alzheimer&apos;s disease. Guoji Zhongyi Zhongyao Zazhi. 2020; 42:745-749. (in Chinese)."},{"key":"74","unstructured":"74. Li Q, Chen L, Tang S, Pan C, He J. Clinical study on Jianpi Yangxin Tang combined with donepezil hydrochloride tablets for mild-to-moderate Alzheimer disease of heart-spleen deficiency type. Xin Zhongyi. 2020; 52:59-62. (in Chinese)."},{"key":"75","unstructured":"75. Meng S. Effects of Hengqing II prescription and donepezil hydrochloride on patients with Alzheimer&apos;s disease and its mechanism. Zhongguo Yiyao Daobao. 2021; 18:140-144. (in Chinese)."},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Zhang J, Yang C, Wei D, Li H, Leung EL, Deng Q, Liu Z, Fan XX, Zhang Z. Long-term efficacy of Chinese medicine Bushen Capsule on cognition and brain activity in patients with amnestic mild cognitive impairment. Pharmacol Res. 2019; 146:104319.","DOI":"10.1016\/j.phrs.2019.104319"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Chen Z, Wang X, Du S, Liu Q, Xu Z, Guo Y, Lin X. A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer&apos;s disease based on neuroinflammation. Chin Med. 2024; 19:35.","DOI":"10.1186\/s13020-024-00900-6"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Abdalla FH, Cardoso AM, Pereira LB, Schmatz R, Gon\u00e7alves JF, Stefanello N, Fiorenza AM, Gutierres JM, Serres JD, Zanini D, Pimentel VC, Vieira JM, Schetinger MR, Morsch VM, Mazzanti CM. Neuroprotective effect of quercetin on ectoenzyme and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats. Mol Cell Biochem. 2013; 381:1-8.","DOI":"10.1007\/s11010-013-1659-x"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Lee SY, Chiu YJ, Yang SM, Chen CM, Huang CC, Lee-Chen GJ, Lin W, Chang KH. Novel synthetic chalcone-coumarin hybrid for A\u03b2 aggregation reduction, antioxidation, and neuroprotection. CNS Neurosci Ther. 2018; 24:1286-1298.","DOI":"10.1111\/cns.13058"},{"key":"80","unstructured":"80. Luo J, Huang Y, Zheng H, Wei J, Tu Q. Screening and mechanistic studies of anti-Alzheimer&apos;s fractions of Anemarrhenae Rhizoma. Shijie Kexue Jishu Zhongyiyao Xiandaihua. 2020; 22:3030-3035. (in Chinese)."},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Yang ZD, Duan DZ, Du J, Yang MJ, Li S, Yao XJ. Geissoschizine methyl ether, a corynanthean-type indole alkaloid from Uncaria rhynchophylla as a potential acetylcholinesterase inhibitor. Nat Prod Res. 2012; 26:22-28.","DOI":"10.1080\/14786419.2010.529811"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Xia J, Cai M, Xu B, Xie GJ, Wang P. Comparative study on sedative and hypnotic effects of crude and parched Semen Ziziphi Spinosae: Integration of network pharmacology and <i>in vivo<\/i> pharmacological evaluation. Curr Comput Aided Drug Des. 2025; 21:573-586.","DOI":"10.2174\/0115734099281920240730051328"},{"key":"83","unstructured":"83. Wang HP. Mechanism of improving learning and memory in Alzheimer&apos;s disease model rats by Angelica volatile oil. Tianran Chanwu Yanjiu Yu Kaifa. 2022; 34:836-841. (in Chinese)."},{"key":"84","unstructured":"84. Min Z. PSP improves learning and memory and its mechanism. Beihua Daxue Xuebao Ziran Kexue Ban. 2018; 19:39-44. (in Chinese)."},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Zhao J, Li K, Wang Y, Li D, Wang Q, Xie S, Wang J, Zuo Z. Enhanced anti-amnestic effect of donepezil by Ginkgo biloba extract (EGb 761) <i>via<\/i> further improvement in pro-cholinergic and antioxidative activities. J Ethnopharmacol. 2021; 269:113711.","DOI":"10.1016\/j.jep.2020.113711"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Chen DL, Zhang P, Lin L, Zhang HM, Deng SD, Wu ZQ, Ou S, Liu SH, Wang JY. Protective effects of bajijiasu in a rat model of A\u03b225-35-induced neurotoxicity. J Ethnopharmacol. 2014; 154:206-217.","DOI":"10.1016\/j.jep.2014.04.004"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Wang D, Wang C, Liu L, Li S. Protective effects of evodiamine in experimental paradigm of Alzheimer&apos;s disease. Cogn Neurodyn. 2018; 12:303-313.","DOI":"10.1007\/s11571-017-9471-z"},{"key":"88","unstructured":"88. Piao Z, Jiang X, Luo S, Bai C, Ling L, Yin F. Effects of Zuogui Pill on HSP70 and ultrastructure of brain neurons in senile dementia model rats. Zhongguo Laonianxue Zazhi. 2009; 29:161-163. (in Chinese)."},{"key":"89","unstructured":"89. Chen M, Ma QY. Effects of Buyuan Congnao Decoction on rats with Alzheimer&apos;s disease. Shizhen Guoyi Guoyao. 2010; 21:3167-3168. (in Chinese)."},{"key":"90","unstructured":"90. Wu ZZ, Tian XX, Liu Y, Hu L, Li YH, Li M. Effect of Qinggan Jieyu method on central cholinergic system activity in a senile dementia model. Zhongyiyao Xuekan. 2009; 16:473-474. (in Chinese)."},{"key":"91","unstructured":"91. Bai LM, Zhang XS, Wu M, Yang R. Influence of Dihuangyinzi on learning and memory and hippocampal AChE and ChAT in rats with chronic cerebral hypoperfusion. Zhongguo Shiyan Fangjixue Zazhi. 2011; 17:207-209. (in Chinese)."},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Chua KK, Wong A, Kwan PW, Song JX, Chen LL, Chan AL, Lu JH, Mok V, Li M. The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer&apos;s disease: Protocol for a randomized controlled trial. Trials. 2015; 16:199.","DOI":"10.1186\/s13063-015-0716-z"},{"key":"93","unstructured":"93. Gao X, Bai R, Jing R, Han XP, Zang L. Curative effects of Buyuan Congnao Decoction combined with acupuncture in older patients with dementia (kidney deficiency and phlegm stasis pattern) and effects on MMSE, Hcy and A\u03b2. Shijie Zhongyiyao. 2019; 14:144-148. (in Chinese)."}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/advpub\/0\/advpub_2026.01106\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:25:25Z","timestamp":1787977525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/advpub\/0\/advpub_2026.01106\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":93,"URL":"https:\/\/doi.org\/10.5582\/bst.2026.01106","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2026.01106"}}